DMAAU Drugs Made in America Acquisition Corp.

Fundamentals / CIK 0002028614 / USD
Other share classes on CIK 0002028614: DMAA DMAAR

Drugs Made in America Acquisition Corp. reported $147.5M in total assets and net income of $5.16M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DMAAU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31
Operating Income -$2.82M
Interest Income $8.76M
Net Income $5.94M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Operating Income -$96K -$137K -$143K -$2.09M -$264K -$132K -$331K -$145K
Interest Income $1.34M $1.86M $2.11M $2.30M $2.45M $2.42M $1.59M --
Net Income $1.24M $1.73M $1.97M $213K $2.18M $2.29M $1.25M -$145K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $6.1K $1.4K
Cash & Short-Term Investments $6.1K $1.4K
Total Current Assets $12K $5.0K
Total Non-Current Assets $239.9M $546K
Total Assets $239.9M $551K
Total Current Liabilities $376K $796K
Deferred Revenue (Non-Current) $6.90M --
Total Non-Current Liabilities $6.90M $0
Total Liabilities $7.28M $796K
Common Stock $1.1K $986
Retained Earnings -$7.27M -$280K
Total Stockholders' Equity -$7.26M -$245K
Total Equity -$7.26M -$245K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $17K $20K $15K $6.1K $717 $822 $923 $1.4K
Cash & Short-Term Investments $17K $20K $15K $6.1K $717 $822 $923 $1.4K
Total Current Assets $49K $69K $15K $12K $28K $50K $71K $5.0K
Total Non-Current Assets $147.4M $146.8M $242.0M $239.9M $237.6M $235.2M $232.7M $546K
Total Assets $147.5M $146.9M $242.0M $239.9M $237.6M $235.2M $232.8M $551K
Total Current Liabilities $2.26M $2.94M $492K $376K $457K $301K $347K $796K
Deferred Revenue (Non-Current) -- -- -- $6.90M -- -- -- --
Total Non-Current Liabilities $6.19M $6.19M $6.90M $6.90M $6.90M $6.90M $6.90M $0
Total Liabilities $8.45M $9.14M $7.39M $7.28M $7.36M $7.20M $7.25M $796K
Common Stock $1.1K $1.1K $1.1K $1.1K $1.1K $1.1K $1.1K $986
Retained Earnings -$8.40M -$7.41M -$7.38M -$7.27M -$6.72M -$6.46M -$6.33M -$280K
Total Stockholders' Equity -$8.40M -$7.41M -$7.38M -$7.26M -$7.33M -$7.15M -$7.18M -$245K
Total Equity -$8.40M -$7.41M -$7.38M -$7.26M -$7.33M -$7.15M -$7.18M -$245K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31
Net Income $5.94M
Operating Cash Flow -$539K
Investing Cash Flow -$231.2M
Financing Cash Flow $231.7M
Net Change in Cash $4.8K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Net Income $1.24M $1.73M $1.97M $213K $2.18M $2.29M $1.25M -$145K
Operating Cash Flow -$78K -$245K -$91K -$125K -$56K -$107K -$251K --
Investing Cash Flow -- -- -- $0 $0 $0 -$231.2M --
Financing Cash Flow $975K -$98.46M $100K $131K $56K $107K $231.4M --
Net Change in Cash -$3.3K $5.4K $8.8K $5.4K -$105 -$101 -$428 --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31
Return on Assets (ROA) 2.5%
Current Ratio 0.03x
Quick Ratio 0.02x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Return on Assets (ROA) 3.5% 4.1% 2.8% 2.5% -- -- -- --
Current Ratio 0.02x 0.02x 0.03x 0.03x 0.06x 0.16x 0.20x --
Quick Ratio 0.01x 0.01x 0.03x 0.02x 0.00x 0.00x 0.00x --
Net Income Growth (YoY) -43.0% -24.5% +57.1% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002028614) · from September 30, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal